Integra LifeSciences Holdings CorporationIARTNASDAQ
LOADING
|||
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-3.26%
↓ 261% below average
Average (39q)
2.03%
Historical baseline
Range
High:43.13%
Low:-27.00%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -3.26% |
| Q2 2025 | 8.61% |
| Q1 2025 | -13.55% |
| Q4 2024 | 16.23% |
| Q3 2024 | -8.93% |
| Q2 2024 | 13.37% |
| Q1 2024 | -7.09% |
| Q4 2023 | 3.82% |
| Q3 2023 | 0.30% |
| Q2 2023 | 0.11% |
| Q1 2023 | -4.32% |
| Q4 2022 | 3.33% |
| Q3 2022 | -3.17% |
| Q2 2022 | 5.62% |
| Q1 2022 | -7.12% |
| Q4 2021 | 4.82% |
| Q3 2021 | -0.80% |
| Q2 2021 | 8.31% |
| Q1 2021 | -7.35% |
| Q4 2020 | 4.97% |
| Q3 2020 | 43.13% |
| Q2 2020 | -27.00% |
| Q1 2020 | -10.33% |
| Q4 2019 | 4.23% |
| Q3 2019 | -1.19% |
| Q2 2019 | 6.66% |
| Q1 2019 | -6.16% |
| Q4 2018 | 4.77% |
| Q3 2018 | -0.09% |
| Q2 2018 | 2.55% |
| Q1 2018 | -3.13% |
| Q4 2017 | 32.19% |
| Q3 2017 | -1.18% |
| Q2 2017 | 9.10% |
| Q1 2017 | 1.16% |
| Q4 2016 | 2.13% |
| Q3 2016 | 0.41% |
| Q2 2016 | 5.30% |
| Q1 2016 | -1.82% |
| Q4 2015 | 6.53% |